Correspondence 0001493152-23-033037 from ENvue Medical, Inc. (FEED)

ENvue Medical, Inc.
Date: Sept. 19, 2023 · CIK: 0001326706 · Accession: 0001493152-23-033037

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-274482

Date

Sept. 19, 2023

Author

Not clearly detected

Form

CORRESP

Company

ENvue Medical, Inc.

Letter

NanoVibronix, Inc.

Executive Boulevard

Elmsford, New York 10523

September 19, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

Securities and Exchange Commission

Washington, D.C. 20549

Attention: Nicholas O’Leary

Re: NanoVibronix, Inc.

Registration Statement on Form S-3

Filed on September 12, 2023

File No. 333-274482 (the “Registration Statement”)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, NanoVibronix, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 10:00 a.m., Eastern Time, on September 21, 2023, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Jayun Koo, Esq. at (212) 835-4823.

Very truly yours,
NANOVIBRONIX, INC.

Show Raw Text

CORRESP
1
filename1.htm

NanoVibronix,
Inc.

525
Executive Boulevard

Elmsford,
New York 10523

September
19, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Industrial Applications and Services

Securities
and Exchange Commission

Washington,
D.C. 20549

Attention:
Nicholas O’Leary

    Re:
    NanoVibronix,
    Inc.

Registration
Statement on Form S-3

Filed
on September 12, 2023

File No.  333-274482 (the “Registration Statement”)

Request
for Acceleration

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933, as amended, NanoVibronix, Inc. (the “Company”) hereby respectfully requests acceleration
of the effective date of the Registration Statement, so that it may become effective at 10:00 a.m., Eastern Time, on September
21, 2023, or as soon thereafter as practicable.

Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes
and Boone, LLP, attention: Jayun Koo, Esq. at (212) 835-4823.

    Very truly yours,

    NANOVIBRONIX, INC.

    By:
    /s/ Brian
    Murphy

    Brian Murphy

    Chief Executive Officer

  cc:
  Jayun Koo, Esq., Haynes and Boone, LLP

SecProbe.io